Archive for 2015

Comment by pat_swap

View Single Comment

  1. pat_swap

    Phil/ rtd,
    This is very useful. I was just thinking of how to get days from tos into excel. I will use this for our prototype.

    Thanks as always.

Credit Suisse Names Top Picks For Gold Stocks In 2015

Courtesy of Benzinga.

Credit Suisse Names Top Picks For Gold Stocks In 2015

Related AEM
Credit Suisse Is Positive On Gold Equities, Lists 4 Stocks To Buy
Bank Of America Sees Growth Potential From Meliadine And IVR For Agnico Eagle Mines

Related EGO
UPDATE: Canaccord Downgrades Eldorado Gold
3 Gold Stocks to Shine This Earnings Season – Earnings ESP

Credit Suisse issued a gold sector report Monday and named its top picks.

Analyst Anita Soni prefered Agnico Eagle Mines Ltd (USA) (NYSE: AEM) with a $35 target price “for its lower cost assets, operational consistency, strong FCF and growth in 2015.”

Eldorado Gold Corp (USA) (NYSE: EGO) with an $8 price target was preferred “for its strong balance sheet and organic growth opportunities.”

Goldcorp Inc. (USA) (NYSE: GG) with a $24 price target was the “preferred senior stock on a 12-month view for its relatively strong balance sheet and growth.”

Franco-Nevada Corporation (NYSE: FNV) with a $61 price target was the “preferred defensive gold stock due to its royalty/streaming model and ability to execute on accretive acquisitions.”

Overall, the firm was positive on gold equities for 2015. Soni saw “outperformance driven by (i) margin expansion; (ii) gold price stability; and (iii) renewed interest in the space (potential sector rotation and M&A).”

“Gold equities represent an investment in a commodity more tied to global monetary policy and consumer demand in emerging markets (in particular China and India) than alternatives in the commodity complex. Alternatives for resource investors such as oil, base metals and iron ore face the challenge of a more recent commodity price correction, the implications of which may not yet be fully priced into the stocks,” according to the analyst report.

All of the above top picks were up over 3 percent Monday with Eldorado Gold leading the group, trading up 4.01 percent at $7.01.

Latest Ratings for AEM

Date Firm Action From To
Nov 2014 Barclays Maintains Equal-weight
Oct 2014 Barclays Maintains Equal-weight
Oct 2014 Scotia Capital Upgrades Sector Perform Sector Outperform

View More Analyst Ratings for AEM
View the Latest Analyst Ratings

Posted-In: Anita Soni Credit SuisseAnalyst Color Long Ideas Price Target Analyst Ratings Trading Ideas Best of Benzinga

FBR: Marvell Technology Won't Discount Wireless Unit

Courtesy of Benzinga.

Related MRVL
Standpoint Research Downgrades Marvell Technology Group
JP Morgan Sees 'Neutral Impact' On Hewlett-Packard And Corning At CES 2015

Marvell Technology Group Ltd. (NASDAQ: MRVL) is keeping investors in suspense about a supposedly "game-changing" technology planned for the current quarter, an analyst said Monday.

FBR's Christopher Rolland speculated the technology may integrate radio frequency into the computer component maker's cellular mobile platform.

Rolland, who made the comment in a research note following his attendance at the annual Consumer Electronics Show in Las Vegas, also said Marvell was equally tight-lipped about recent rumors it may sell its wireless unit.

Rolland maintained a Market Perform rating on Marvell, and said the company was "extremely optimistic" that its wireless unit can maintain its 30 percent market share for fourth-generation chips in China, and that it can double the volume of units sold there during 2015.

The optimism suggests that Marvell won't sell the unit for a discounted price of $500 million or less, Rolland said.

Rolland further speculated that Marvell could enter the market for ARM servers later this year.

Hewlett-Packard Company (NASDAQ: HPQ) recently became the first major vendor to offer an ARM server, with Microsoft Corporation (NASDAQ: MSFT) and Dell Computer reportedly studying similar moves.

If Marvell obtains a license on the technology, it could prove a boon to ARM Holdings plc (NASDAQ: ARMH), Rolland said.

Marvell closed Monday at $15.92, down 0.69 percent.

Latest Ratings for MRVL

Date Firm Action From To
Jan 2015 Standpoint Research Downgrades Buy Hold
Nov 2014 Deutsche Bank Maintains Hold
Nov 2014 Morgan Stanley Maintains Equal-weight

View More Analyst Ratings for MRVL
View the Latest Analyst Ratings

Posted-In: Christopher Rolland FBRAnalyst Color News Rumors Reiteration Asset Sales Analyst Ratings

JP Morgan: Apple Has Caught Up With U.S. iPhone 6 Demand, Neutral Impact To Shares

Courtesy of Benzinga.

Related AAPL
More Analysts Agree: The Apple Watch Could Be The Company's 'Most Successful Product'
Apple Created A Special Team To Win Sony's Former Customers
Venture Capital Trends for 2015 and Beyond (Fox Business)

JP Morgan’s Rod Hall on Monday commented that Apple Inc. (NASDAQ: AAPL) has now caught up with domestic iPhone 6 demand, as consumers will no longer be forced to wait when purchasing an iPhone 6 or iPhone 6 Plus.

According to Hall’s checks at Apple retail outlets in the Southern U.S., only the sim-free iPhone 6 Plus comes with a lead time of just one day. The analyst adds that other than the sim-free device, all configurations are listed as “in stock.”

However, Hall notes that this development has a neutral impact to shares. The analyst notes that this development is consistent with the company’s commentary during its fourth quarter conference call where the company indicated that iPhone supply demand should reach a balance by the end of 2014.

Shares of Apple recently traded at $110.02, down 1.7 percent.

Latest Ratings for AAPL

Date Firm Action From To
Dec 2014 Citigroup Maintains Buy
Dec 2014 JMP Securities Maintains Market Outperform
Dec 2014 Canaccord Genuity Maintains Buy

View More Analyst Ratings for AAPL
View the Latest Analyst Ratings

Posted-In: iPhone iPhone 6 iPhone 6 Plus JPMorgan Rod HallAnalyst Color Analyst Ratings

Nomura Upgrades Alcoa, Cites Stabilized Packaging Margin

Courtesy of Benzinga.

Related AA
Alcoa Up 2% Amid Nomura Upgrade Ahead Of Q4 Earnings Report
Benzinga's Top Upgrades
Week Ahead: Bank Earnings, Inflation Reports (Fox Business)

Alcoa Inc (NYSE: AA) will benefit from stabilized profit margins in its packaging business as well as accelerating growth in its automotive sector, an analyst said Monday.

Nomura's Curt Woodworth upgraded Alcoa to Buy and boosted his price target on the company 23 percent to $23 a share.

The aluminum producer changed hands recently at $16.11, unchanged.

Alcoa is set to post fourth-quarter and full-year results after Monday's bell.

Woodworth raised his 2014 estimate to $0.91 a share, from $0.80 a share; analysts on average expect 2014 earnings of $1 a share.

Alcoa's packaging segment, which mostly makes aluminum cans, has seen its capacity displaced by the company's automotive segment, according to Woodworth.

This trend "should stabilize packaging margins" Woodworth said, while significant growth in automotive should increase the company's earnings before interest, taxes, depreciation and amortization.

Meanwhile, a strong dollar will add $0.20 a share in annual earnings, Woodworth said.

"With [Alcoa's] earnings set to be released this week, the stock has two key prices to watch," CMT Christian Tharp told Benzinga. "First, a break above the resistance area surrounding $17.50 should lead to higher prices for the stock. However, a break below $15 on a bad earnings report could lead to much lower prices for [Alcoa]."

Latest Ratings for AA

Date Firm Action From To
Jan 2015 Nomura Upgrades Neutral Buy
Dec 2014 Wells Fargo Initiates Coverage on Outperform
Dec 2014 Citigroup Maintains Neutral

View More Analyst Ratings for AA
View the Latest Analyst Ratings

Posted-In: Curt Woodworth NomuraAnalyst Color Upgrades Price Target Analyst Ratings

Barclays Upgrades CH Robinson Worldwide To Overweight

Courtesy of Benzinga.

Related CHRW
Credit Suisse's 5 Industrial Stocks To Avoid
A Pair Of Upgrades For C.H. Robinson
Dow Transports Slump on Profit Taking, Economic Worries (Fox Business)

Analysts at Barclays upgraded CH Robinson Worldwide Inc. (NASDAQ: CHRW) from Equal-weight to Overweight.

The price target for CH Robinson Worldwide has been raised from $70 to $80.

CH Robinson Worldwide shares have jumped 25.43% over the past 52 weeks, while the S&P 500 index has gained 12.40% in the same period.

CH Robinson Worldwide’s shares fell 1.07% to close at $72.06 on Friday.

Latest Ratings for CHRW

Date Firm Action From To
Jan 2015 Barclays Upgrades Equal-weight Overweight
Jan 2015 RBC Capital Upgrades Underperform Sector Perform
Jan 2015 Goldman Sachs Upgrades Sell Neutral

View More Analyst Ratings for CHRW
View the Latest Analyst Ratings

Posted-In: BarclaysUpgrades Analyst Ratings

Jefferies Initiates Bellicum Pharmaceuticals At Buy

Courtesy of Benzinga.

Related BLCM
Stocks Hitting 52-Week Lows
Benzinga's Top #PreMarket Losers

Analysts at Jefferies initiated coverage on Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) with a Buy rating.

The target price for Bellicum Pharmaceuticals is set to $35.

Bellicum Pharmaceuticals’ shares jumped 10.86% to close at $31.75 on Friday.

Latest Ratings for BLCM

Date Firm Action From To
Jan 2015 Jefferies Initiates Coverage on Buy
Jan 2015 Piper Jaffray Initiates Coverage on Overweight
Jan 2015 Jefferies Initiates Coverage on

View More Analyst Ratings for BLCM
View the Latest Analyst Ratings

Posted-In: JefferiesInitiation Analyst Ratings

Benzinga's Top #PreMarket Gainers

Courtesy of Benzinga.

Related FMI
US Stock Futures Signal Higher Start On Wall Street
Foundation Medicine Signs Data Partnership With Cota, Inc

Related RHHBY
What Investors Are Looking For After Seeing Unusual Options Activity In Halozyme
Benzinga's M&A Chatter for Tuesday December 2, 2014

Foundation Medicine, Inc. (NASDAQ: FMI) shares gained 106.52% to $49.44 in the pre-market trading session after Roche Holding AG (OTC: RHHBY) announced its plans to acquire up to 56.3% stake in Foundation Medicine for $1.03 billion. Roche will commence tender offer at $50.00 per share.

Tekmira Pharmaceuticals Corp (NASDAQ: TKMR) shares jumped 47.42% to $23.10 in pre-market trading on merger deal with OnCore Biopharma Inc.

Abengoa SA (ADR) (NASDAQ: ABGB) shares surged 14.04% to $14.95 in pre-market trading after the company announced the commencement of a 9.2 million secondary public offering of its shares of Abengoa Yield by selling shareholder Abengoa.

NPS Pharmaceuticals, Inc.(NASDAQ: NPSP) shares rose 8.52% to $45.48 in pre-market trading after Shire PLC (NASDAQ: SHPG) agreed to buy NPS Pharmaceuticals for $5.2 billion, or $46 per share.

MWI Veterinary Supply, Inc. (NASDAQ: MWIV) gained 5.78% to $185.81 in pre-market trading after AmerisourceBergen Corporation (NYSE: ABC) reported the purchase of MWI Veterinary Supply for $190 per share in cash.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

Northland Securities Initiates Accuray At Outperform

Courtesy of Benzinga.

Related ARAY
Brean Capital Sees Limited 2Q15 Visibility For Accuray
Midday Losers From October 30: Glu Mobile, Niska Gas Storage, Yamana Gold And More

Analysts at Northland Securities initiated coverage on shares of Accuray (NASDAQ: ARAY) with a Outperform rating.

The target price for Accuray is set to $11.

Accuray shares have dropped 19.60% over the past 52 weeks, while the S&P 500 index has gained 12.40% in the same period.

Accuray’s shares fell 2.13% to close at $6.89 on Friday.

Latest Ratings for ARAY

Date Firm Action From To
Jan 2015 Northland Securities Initiates Coverage on Outperform
Jun 2014 JP Morgan Upgrades Neutral Overweight
Mar 2014 BTIG Research Initiates Coverage on Buy

View More Analyst Ratings for ARAY
View the Latest Analyst Ratings

Posted-In: Northland SecuritiesInitiation Analyst Ratings

UPDATE: Jefferies Raises Price Target On Flowserve On Process Capex Update

Courtesy of Benzinga.

Related FLS
Bank Of America Issues Downgrade, Lowers Guidance For Upstream Oil & Gas Plays
Benzinga's Top Upgrades

In a report published Monday, Jefferies analyst R. Scott Graham reiterated a Buy rating on Flowserve Corp (NYSE: FLS), and raised the price target from $76.00 to $68.00.

In the report, Jefferies noted, “Oil & Gas is the largest market served by our manufacturing companies. We track >$600B of capital spending of global O&G companies in our quarterly Process Capex report. Based on company capex budgets and inputs from Jefferies Energy Teams, we estimated 2015 O&G capex would be -8% in our Process Capex report (12/19/14). With additional budgets announced since then, we now expect spending to be -12%. We are lowering estimates on ATU, FLS, NES, NWPX and THR.”

Flowserve closed on Friday at $57.09.

Latest Ratings for FLS

Date Firm Action From To
Jan 2015 Jefferies Maintains Buy
Jan 2015 Stifel Nicolaus Maintains Buy
Dec 2014 Barclays Maintains Overweight

View More Analyst Ratings for FLS
View the Latest Analyst Ratings

Posted-In: Jefferies R. Scott GrahamAnalyst Color Price Target Analyst Ratings


Zero Hedge

Americans' Economic Hope Has Collapsed

Courtesy of ZeroHedge. View original post here.

Which came first, the confidence or the stock market rally?

One thing is for sure, the crash in stocks in December has crushed the hope of Americans that their economic future is going to be better under President Trump.

Overall confidence dipped to 58.1 - a 4-month low, but, U.S. consumers this month were the most downbeat on the economy since November 2016, a third straight drop after expectations reached a 16-year high just three months earlier, as the partial government shutdown wears on toward a fourth week.


more from Tyler

Kimble Charting Solutions

Triple Breakout Test In Play For S&P 500!

Courtesy of Chris Kimble.

Is the rally of late about to run out of steam or is a major breakout about to take place in the S&P 500? What happens at current prices should go a long way in determining this question.

This chart looks at the equal weight S&P 500 ETF (RSP) on a daily basis over the past 15-months.

The rally from the lows on Christmas Eve has RSP testing the top of a newly formed falling channel while testing the underneath side of the 2018 trading range and its falling 50-day moving average at (1).

At this time RPS is facing a triple resistance test. Wil...

more from Kimble C.S.

Phil's Favorites

Brexit deal flops, Theresa May survives -- so what happens now?


Brexit deal flops, Theresa May survives -- so what happens now?

Courtesy of Victoria Honeyman, University of Leeds

As the clock ticks down to March 29 2019, all of the political manoeuvring, negotiating, arguing and fighting is coming to a peak. In the two and a half years since the 2016 EU referendum, views on both sides have hardened and agreement still seems as far away as it was the day after the referendum.

With Theresa May’s withdrawal agreement disliked by all sides, and voted down by an unprecedented majority in the House of Commons, everyone is wondering what can and should be done next?


more from Ilene

Digital Currencies

Crypto-Bubble: Will Bitcoin Bottom In February Or Has It Already?

Courtesy of Michelle Jones via

The new year has been relatively good for the price of bitcoin after a spectacular collapse of the cryptocurrency bubble in 2018. It’s up notably since the middle of December and traded around the psychological level of $4,000... so is this a sign that the crypto market is about to recover?

Of course, it depends on who you ask, but one analyst discovered a pattern which might point to a bottom next month.

A year after the cryptocurrency bubble popped


more from Bitcoin


D.E. Shaw Investment Calls For Leadership Change At EQT

By ActivistInsight. Originally published at ValueWalk.

Elliott Management has offered to acquire QEP Resources for approximately $2.1 billion, contending the oil and gas explorer’s turnaround efforts have done little to lift the company’s share price. The company responded and said that a thorough review of the proposition is imperative in order to properly act in the best interests of shareholders, “taking into account the company’s other alternatives and current market conditions.” The news came only a month after Travelport Worldwide agreed to sell itself to Siris Capital Group and Elliott’s private equity arm Evergreen Coast Capital for $4.4 billion in cash and two months after Athenahealth was bought by Veritas and Evergreen for $5.7 bi...

more from ValueWalk

Insider Scoop

UBS Says Disney's Streaming Ambition Gives It A 'New Hope'

Courtesy of Benzinga.

Related DIS Despite Some Risks, Analysts Still Expecting Double Digit Growth From Communications Services In Q4 ... more from Insider

Chart School

Weekly Market Recap Jan 13, 2019

Courtesy of Blain.

In last week’s recap we asked:  “Has the Fed solved all the market’s problems in 1 speech?”

Thus far the market says yes!  As Guns n Roses preached – all we need is a little “patience”.  Four up days followed by a nominal down day Friday had the market following it’s normal pattern the past nearly 30 years – jumping whenever the Federal Reserve hints (or essentially says outright) it is here for the markets.   And in case you missed it the prior Friday, Chairman Powell came back out Thursday to reiterate the news – so…so… so… patient!

Fed Chairman Jerome Powell reinforced that message Thursday during a discussion at the Economic Club of Washington where he said that the central bank will be “fle...

more from Chart School

Members' Corner

Why Trump Can't Learn


Bill Eddy (lawyer, therapist, author) predicted Trump's chaotic presidency based on his high-conflict personality, which was evident years ago. This post, written in 2017, references a prescient article Bill wrote before Trump even became president, 5 Reasons Trump Can’t Learn. ~ Ilene 

Why Trump Can’t Learn

Donald Trump by Gage Skidmore (...

more from Our Members


Opening Pandora's Box: Gene editing and its consequences

Reminder: We are available to chat with Members, comments are found below each post.


Opening Pandora's Box: Gene editing and its consequences

Bacteriophage viruses infecting bacterial cells , Bacterial viruses. from

Courtesy of John Bergeron, McGill University

Today, the scientific community is aghast at the prospect of gene editing to create “designer” humans. Gene editing may be of greater consequence than climate change, or even the consequences of unleashing the energy of the atom.


more from Biotech

Mapping The Market

Trump: "I Won't Be Here" When It Blows Up

By Jean-Luc

Maybe we should simply try him for treason right now:

Trump on Coming Debt Crisis: ‘I Won’t Be Here’ When It Blows Up

The president thinks the balancing of the nation’s books is going to, ultimately, be a future president’s problem.

By Asawin Suebsaeng and Lachlan Markay, Daily Beast

The friction came to a head in early 2017 when senior officials offered Trump charts and graphics laying out the numbers and showing a “hockey stick” spike in the nationa...

more from M.T.M.


Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.


This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

more from OpTrader


Free eBook - "My Top Strategies for 2017"



Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:


·       How 2017 Will Affect Oil, the US Dollar and the European Union


more from Promotions

About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

As Seen On:

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>